Nasal delivery of recombinant human growth hormone: In vivo evaluation with pheroid™ technology and N-trimethyl chitosan chloride

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 2, 2010, Pages 263-273

  Steyn, Dewald ^a   du Plessis, Lissinda ^a   Kotzé, Awie ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; HUMAN GROWTH HORMONE; N TRIMETHYL CHITOSAN CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MORPHOLOGY; NONHUMAN; NOSE CAVITY; PARTICLE SIZE; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 78650388990     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3cs3f     Document Type: Article

References (27)

1. Krysiak R, Gdula-Dymek A, Bednarska- Czerwiñska A, Okopieñ B - Growth hormone therapy in children and adults. Pharmocol Reports, 59: 500-516,2007.
2. Laursen T, Gravholt CH, Heickendorff L, Drustrup J, Appelgaard A, Jørgensen JOL, Christiansen JS. - Long-Term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults. J Clinical Endocrinol Metabolism, 86: 1222-1228, 2001.
3. Laursen T, Grandjean B, Jorgensen JO, Christiansen JS - Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GHdeficient patients: comparison with intravenous and subcutaneous administration. Eur J Endocrinol, 135: 309-315, 1996.
4. Illum L. - Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci, 96: 473-483, 2007.
5. Dass CR, Choong PF. - Carrier-mediated delivery of peptidic drugs for cancer therapy. Peptides, 27: 3020-3028, 2006.
6. Thanou M, Verhoef JC, Junginger HE. - Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Delivery Rev, 52: 117-126, 2001.
7. Sarciaux JM, Acar L, Sado PA. - Using microemulsion formulations for oral drug delivery of therapeutic peptides. Int J Pharm, 120: 127-136, 1995.
8. Deli MA. - Potential use of tight junction modulators to reversibly open membraneous barriers and improve drug delivery, Biochim et Biophys Acta, 1788, 892-910, 2009.
9. Hamman JH, Enslin GM, Kotzé AF. - Oral delivery of peptide drugs: barriers and developments. Biodrugs, 19: 165-177, 2005.
10. Illum L, Farraj NF, Davis SS, Johansen BR, O'Hagan DT. - Investigation of the nasal absorption of biosynthetic human growth hormone in sheep-use of a bioadhesive microsphere delivery system. Int J Pharm, 63: 207-211, 1990.
11. Cheng Y-H, Dyer AM, Jabbal-Gill I, Hinchcliffe M, Nankervis R, Smith A, Watts P. - Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations. Eur J Pharm Sci, 26: 9-15, 2005.
12. Leitner VM, Guggi D, Krauland AH, Bernkop-Schnqrch A. - Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. J. Control. Release 100: 87-95, 2004.
13. Grobler A, Kotzé A, Du Plessis J. - The design of a skin-friendly carrier for cosmetic compounds using Pheroid™ technology. - In WIECHERS, J., Ed. Delivery system technologies. Wheaton, IL.: 2007 pp.).
14. Saunders JCJ, Davis HJ, Coetzee L, Botha S, Kruger AE, Grobler A. - A novel skin penetration enhancer: Evalution by membrane diffusion and confocal microscopy. J Pharmacy Pharm Sci, 2: 99-107, 1999.
15. Du Plessis LH, Lubbe J, Strauss T, Kotzé AF. - Enhancement of nasal and intestinal calcitonin delivery by the novel PheroidTM fatty acid based delivery system, and by Ntrimethyl chitosan chloride. Int. J. Pharm. 385:181-186, 2010.
16. Kotzé AF, Lueßen HL, De Boer AG, Verhoef JC, Junginger HE. - Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments. Eur J Pharm Sci, 7: 145-151, 1998a.
17. Kotzé AF, Lueßen HL, De Leeuw BJ, De Boer AG, Verhoef JC, Junginger HE. - Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Control. Release, 51: 35-46, 1998b.
18. Kotzé AF, Thanou MM, Lueben HL, De Boer AGD, Verhoef JC, Junginger, HE. - Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco- 2). J Pharm Sci, 88: 253-257, 1999.
19. Jonker C, Hamman JH, Kotzé AF. - Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation. Int J Pharm, 238: 205-213, 2002.
20. Kotzé AF, De Leeuw BJ, Lueßen HL, De Boer AG, Verhoef JC, Junginger HE. - Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers. Int J Pharm, 159: 243-253, 1997.
21. Van Der Merwe SM, Verhoef JC, Verheijden JHM, Kotzé AF, Junginger HE. - Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur. J. Pharm. Biopharm, 58: 225-235, 2004.
22. Van der Lubben IM, Verhoef JC, Borchard G, Junginger HE - Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci, 14: 201-207, 2001.
23. Snyman D, Govender T, Kotzé AF. - Low molecular weight quaternised chitosan (I): synthesis and characterisation, Pharmazie, 58:705-708, 2003.
24. Almeida AJ, Souto E. - Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev, 59: 478-490, 2007.
25. Bilati U, Allémann E, Doelker E. - Strategic approaches for overcoming peptide and protein instability within biodegradable nanoand microparticles. Eur J Pharm Biopharm, 59: 375-388, 2005.
26. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. - Nano/microtechnologies for delivering macromolecular therapeutics using poly(d,llactide- co-glycolide) and its derivatives. J. Control. Release 125: 193-209, 2008.
27. Hamman JH, Stander M, Kotzé AF. - Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm, 232: 235-242, 2002.